◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › WALD

Waldencast plc (WALD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Defensive · Household & Personal Products · DATA UPDATED 2026-07-10

Waldencast plc (WALD) operates in the Household & Personal Products industry and is headquartered in London, United Kingdom with about 367 employees. Its market capitalization is roughly $221 million. In the fiscal year ended 2025-12-31, WALD reported $272M in revenue and ($230M) in net income.

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup.

Interactive charts & full statements → Open the WALD valuation workbench →

WALD Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312021-12-31
Total Revenue$272M$274M$218M$142M
Gross Profit$183M$192M$142M$87M
Operating Income (EBIT)($65M)($54M)($82M)($2M)
Net Income($230M)($42M)($90M)($20M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WALD Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312021-12-31
Dividends Paid$0M($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WALD Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$746M$976M$1.0B$1.1B
Total Liabilities$246M$246M$273M$290M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WALD viewer.

Other Companies in Household & Personal Products

← WALAll stocksWASH →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.